Gabapentin and Plasma Donation: Why Most Centers Restrict Donation During Treatment

Gabapentin (and its prodrug gabapentin enacarbil) is generally a deferral medication at plasma collection centers.

Rationale

  • Analytical interference: Gabapentin may alter plasma protein electrophoresis, coagulation assays, or viral marker immunoassays, compromising product quality testing.
  • Pharmacodynamic concern: Gabapentin binds α2δ subunit of voltage-gated calcium channels; theoretical risk of altering recipient neurophysiology (though plasma fractionation dilutes/denatures).
  • Regulatory precaution: FDA/EMA guidance treats gabapentin as a “medication affecting plasma safety/quality” pending definitive data.

Center Policy

  • Most centers (CSL Plasma, BioLife, Octapharma, Grifols) require washout period (typically 48 hours to 7 days after last dose) before donation.
  • Disclose all medications at screening; staff will apply current SOP.
  • Do not stop prescribed gabapentin without prescriber approval.

If deferred, ask for written policy and re-evaluation timeline.

Urine Therapy - Related Articles